In a case–control study comparing 21 CAD patients and 20 matched controls, CAD subjects exhibited significantly increased EAT resistin mRNA expression and decreased apelin mRNA, despite no differences in EAT volume or density across groups. The gene discussed is RETN; the disease is coronary artery disorder.